Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aarti Drugs Limited (NSE: AARTIDRUGS), ISIN INE767A01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AARTIDRUGS last traded at ₹444.60 (+1.91%), with a 52-week range of ₹318.60 to ₹533.60 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 54.43%, FIIs 1.52%, DIIs 10.29%, mutual funds 10.08%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.